ArticleArthritis research & therapy2024

CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.

Jingwei Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.